Neve KA - Search Results

1

Commentary on "Novel Interaction of the Dopamine D2 Receptor and the Ca²⁺ Binding Protein S100B: Role in D2 Receptor Function".

Lee HJ, Rodriguez-Contreras D, Neve KA. Lee HJ, et al. Among authors: neve ka. Mol Pharmacol. 2021 Aug;100(2):61-64. doi: 10.1124/molpharm.121.000284. Epub 2021 May 27. Mol Pharmacol. 2021. PMID: 34045267 Free PMC article.

2

Pivotal role for aspartate-80 in the regulation of dopamine D2 receptor affinity for drugs and inhibition of adenylyl cyclase.

Neve KA, Cox BA, Henningsen RA, Spanoyannis A, Neve RL. Neve KA, et al. Among authors: neve rl. Mol Pharmacol. 1991 Jun;39(6):733-9. Mol Pharmacol. 1991. PMID: 1828858

3

Regulation of dopamine D2 receptors by sodium and pH.

Neve KA. Neve KA. Mol Pharmacol. 1991 Apr;39(4):570-8. Mol Pharmacol. 1991. PMID: 2017157

4

Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line.

Neve KA, Henningsen RA, Bunzow JR, Civelli O. Neve KA, et al. Mol Pharmacol. 1989 Sep;36(3):446-51. Mol Pharmacol. 1989. PMID: 2571073

5

Release of dopamine via the human transporter.

Eshleman AJ, Henningsen RA, Neve KA, Janowsky A. Eshleman AJ, et al. Among authors: neve ka. Mol Pharmacol. 1994 Feb;45(2):312-6. Mol Pharmacol. 1994. PMID: 7906856

6

Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.

Watts VJ, Neve KA. Watts VJ, et al. Among authors: neve ka. Mol Pharmacol. 1996 Oct;50(4):966-76. Mol Pharmacol. 1996. PMID: 8863843

7

Activation of type II adenylate cyclase by D2 and D4 but not D3 dopamine receptors.

Watts VJ, Neve KA. Watts VJ, et al. Among authors: neve ka. Mol Pharmacol. 1997 Aug;52(2):181-6. doi: 10.1124/mol.52.2.181. Mol Pharmacol. 1997. PMID: 9271339

8

Constitutive activity of a chimeric D2/D1 dopamine receptor.

Kozell LB, Neve KA. Kozell LB, et al. Among authors: neve ka. Mol Pharmacol. 1997 Dec;52(6):1137-49. doi: 10.1124/mol.52.6.1137. Mol Pharmacol. 1997. PMID: 9396784

9

Contribution of serine residues to constitutive and agonist-induced signaling via the D2S dopamine receptor: evidence for multiple, agonist-specific active conformations.

Wiens BL, Nelson CS, Neve KA. Wiens BL, et al. Among authors: neve ka. Mol Pharmacol. 1998 Aug;54(2):435-44. doi: 10.1124/mol.54.2.435. Mol Pharmacol. 1998. PMID: 9687586

10

Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor.

Neve KA, Cumbay MG, Thompson KR, Yang R, Buck DC, Watts VJ, DuRand CJ, Teeter MM. Neve KA, et al. Mol Pharmacol. 2001 Aug;60(2):373-81. doi: 10.1124/mol.60.2.373. Mol Pharmacol. 2001. PMID: 11455025

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters